Product
Oral Cabotegravir
2 clinical trials
1 indication
Indication
HIV InfectionsClinical trial
Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Females - A Sub-study of HPTN 084Status: Completed, Estimated PCD: 2023-01-10
Clinical trial
A Study of Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) to Maintain Viral Suppression in Adults Living With HIV-1Status: Completed, Estimated PCD: 2024-04-29